Physician profile
David Z Wang
NPI 1831297274
$4,408.18
in general payments reported to CMS, 2019-2025
12 companies · $186 in 2025
The $186 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $3,275 · 2021: $135 · 2022: $547 · 2023: $125 · 2024: $139 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $450.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim (China) Investment Co., LTD. | $3,275.00 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $233.56 | 2021-2022 | |
| Boston Scientific Corporation | $177.20 | 2023-2025 | Watchman Access System, Ekosonic, Lux-Dx Insertable Cardiac Monitor |
| Biosense Webster, INC. | $139.58 | 2022 | |
| Amgen INC. | $139.46 | 2024 | Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $134.11 | 2025 | |
| Alexion Pharmaceuticals, INC. | $127.66 | 2022 | |
| Heartflow, INC. | $99.07 | 2022 | |
| Medtronic, INC. | $59.96 | 2022 | |
| Sk Life Science, INC. | $22.58 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.